EHD2 and hepatocellular carcinoma: Waterfall plots showed that 38.8% and 48.8% of HCC patients showed at least 2-fold upregulation of EHD2 mRNA expression in HCC tissues relative to their NT counterparts in the TCGA database and QMH-HKU cohort, respectively (Supplementary Fig. 7c).